170
Views
12
CrossRef citations to date
0
Altmetric
Case reports

A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab

, , , , , , , & show all
Pages 390-393 | Accepted 19 Mar 2008, Published online: 12 Jul 2009

References

  • Savaşan S., Warrier I., Ravindranath Y. The spectrum of Evans' syndrome. Arch Dis Child 1997; 77: 245–8
  • Sultan S. M., Begum S., Isenberg D. A. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 2003; 42: 230–4
  • Mathew P., Chen G., Wang W. Evans syndrome: results of a national survey. J Pediatr Hematol Oncol 1997; 19: 433–7
  • Kameda T., Dobashi H., Kittaka K., Susaki K., Yamaoka G., Arai K., et al. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment. Clin Rheumatol 2007; 26: 2159–62
  • Cambridge G., Leandro M. J., Teodorescu M., Manson J., Rahman A., Isenberg D. A., et al. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 2006; 54: 3612–22
  • Norton A., Roberts I. Management of Evans syndrome. Br J Haematol 2006; 132: 125–37
  • Mantadakis E., Danilatou V., Stiakaki E., Kalmanti M. Rituximab for refractory Evans syndrome and other immune‐mediated hematologic diseases. Am J Hematol 2004; 77: 303–10
  • van Vollenhoven R. F., Gunnarsson I., Welin‐Henriksson E., Sundelin B., Osterborg A., Jacobson S. H., et al. Biopsy‐verified response of severe lupus nephritis to treatment with rituximab (anti‐CD20 monoclonal antibody) plus cyclophosphamide after biopsy‐documented failure to respond to cyclophosphamide alone. Scand J Rheumatol 2004; 33: 423–7
  • Evans R. S., Takahashi K., Duane R. T., Payne R., Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia. Arch Intern Med 1951; 87: 48–65
  • Silverstein M. N., Heck F. J. Acquired hemolytic anemia and associated thrombocytopenic purpura: with special reference to Evans' syndrome. Proc Staff Meet Mayo Clin 1962; 28;37: 122–8
  • Mylvaganam R., Ahn Y. S., Harrington W. J., Kim C. I., Gratzner H. G. Differences in T cell subsets between men and women with idiopathic thrombocytopenic purpura. Blood 1985; 66: 967–72
  • Karakantza M., Mouzaki A., Theodoropoulou M., Bussel J. B., Maniatis A. Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopenia. Br J Haematol 2000; 110: 968–70
  • Alger M., Alarcon‐Segovia D., Rivero S. J. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol 1977; 4: 351–7
  • Karpatkin S. Autoimmune thrombocytopenic purpura. Blood 1980; 56: 329–43
  • Galor A., O'Brien T. Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome. Int J Hematol 2003; 78: 335–6
  • Park C. Y., Chung C. H. A patient with mixed type Evans syndrome: efficacy of rituximab treatment. J Korean Med Sci 2006; 21: 1115–16
  • Shanafelt T. D., Madueme H. L., Wolf R. C., Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc 2003; 78: 1340–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.